You are here Home Guidance and resources Resources Guidance Medicinal cannabis manufacture Related guidance and further information Technical guidance on the interpretation of the PIC/S Guide to GMP Last updated 10 December 2019 Listen Print Share LinkedIn Twitter Facebook Email Loading... Final decision on scheduling of cannabis and tetrahydrocannabinols Scheduling decision FAQ Office of Drug Control – permits and licences to import Importing unapproved therapeutic goods and controlled substances For enquiries about GMP compliance in the manufacture of medicinal cannabis, contact the Manufacturing Quality Branch. Previous Active pharmaceutical ingredient (API - Part II) Next Version history
